News
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
3d
Everyday Health on MSNFDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention ShotThe new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or ...
He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results